Please use this identifier to cite or link to this item: https://hdl.handle.net/20.500.12530/27890
Title: Phase II study of necitumumab plus modified FOLFOX6 as first-line treatment in patients with locally advanced or metastatic colorectal cancer.
Authors: 
Mesh: 
Issue Date: 16-Feb-2016
Citation: Br. J. Cancer.2016 Feb;(114)4:372-80
Abstract: This single-arm phase II study investigated the EGFR monoclonal antibody necitumumab plus modified FOLFOX6 (mFOLFOX6) in first-line treatment of locally advanced or metastatic colorectal cancer (mCRC).
PMID: 26766738
URI: https://hdl.handle.net/20.500.12530/27890
Rights: openAccess
Appears in Collections:Fundaciones e Institutos de Investigación > IIS H. U. Clínico San Carlos > Artículos

Files in This Item:
File Description SizeFormat 
PMC4815776.pdf306.39 kBAdobe PDFThumbnail
View/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.